Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v14-EN
Language French English
Date Updated 2018-09-28 2018-09-28
Drug Identification Number 00771376 00771376
Brand name APO DILTIAZ TAB 30MG APO DILTIAZ TAB 30MG
Common or Proper name DILTIAZEM DILTIAZEM
Company Name AA PHARMA INC AA PHARMA INC
Ingredients DILTIAZEM HYDROCHLORIDE DILTIAZEM HYDROCHLORIDE
Strength(s) 30MG 30MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 BTL 100 BTL
ATC code C08DB C08DB
ATC description SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF SELECTIVE CALC.CHANNEL BLOCK. W/DIRECT CARDIAC EFF
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-07-10 2017-07-10
Estimated end date 2018-10-19 2018-10-19
Actual end date 2018-09-24 2018-09-24
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments APO-DILTIAZ 30 MG FCT 500 BTL available APO-DILTIAZ 30 MG FCT 500 BTL available
Health Canada comments